New Delhi:
Two Indian positive cases of Covid-19 has been detected, in New Delhi and Telengana.The person from Delhi has a travel history from Italy while the one from Telengana has travel hiostory from Dubai.Both the patients are stable and being cloely monitored.
Giving details about the situation of Coronavirus in India, Union health minister Harsh Vardhan said the ministry and state governments are keeping a close watch and nearly 25,000 people, who have travelled to virus infected countries, are under community surveillance across the country. He informed that passengers from 12 countries are being screened at the various airports and ports across the country.
He also said the government will set up 19 more testing centres in India.More than 2,000 people have been screened at 21 international airports in India in order to contain the disease.
Earlier in India, there were three positive COVID-19 cases reported from Kerala, but all were discharged from the hospital after they recovered from the disease.
The number of deaths globally in the Coronavirus (COVID-19) outbreak crossed 3,000 on Monday, as China reported 42 more deaths. Worldwide, there have been almost 90,000 confirmed cases, with the numbers outside China growing faster than inside China.
The new fatalities were all in the virus epicentre Hubei province of China, the National Health Commission said. In China, the number of reported new cases has gradually been declining and there were only six confirmed new infections outside Hubei. However, South Korea today reported 476 new Coronavirus cases, taking its national tally to 4,212, while the US reported its second death from the virus. Infections have nearly doubled in the past 48 hours in Italy, Europe's worst-hit country.
Meanwhile,Indian drugmaker Sun Pharmaceutical Industries Ltd said on Monday there was a shortage of its generic version of hypertension drug pindolol due to unavailability of supply of the drug's ingredients. The company said it does not source the active pharmaceutical ingredients (API) of the drug from China, adding that supply of some other APIs was impacted by the coronavirus.